Skip to content
20-F

Annual Report (Foreign)

MDXHEALTH SA MDXH

0001213900-25-026226

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 49.5M sh
Current Liabilities FY 2024 · Dec 31, 2023 $19.52M
Total Liabilities FY 2024 · Dec 31, 2023 $121.92M
Current Assets FY 2024 · Dec 31, 2023 $38.16M
Total Assets FY 2024 · Dec 31, 2023 $129.13M
Shares Diluted restated FY 2024 · Dec 31, 2022 15.87M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −$34.12M
Eps Diluted restated FY 2024 · Dec 31, 2022 −$2.78
Eps Basic restated FY 2024 · Dec 31, 2022 −$2.78
Rd Expense restated FY 2024 · Dec 31, 2022 $5.5M
Net Income FY 2024 · Dec 31, 2022 −$44.04M
Operating Income FY 2024 · Dec 31, 2022 −$37.9M
Gross Profit FY 2024 · Dec 31, 2022 $19.22M
Cost Of Revenue FY 2024 · Dec 31, 2022 $17.84M
Revenue FY 2024 · Dec 31, 2022 $37.05M
Cash And Equivalents FY 2024 · Dec 31, 2021 $58.5M
Stockholders Equity FY 2024 · Dec 31, 2021 $46.9M